help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willey, J. C.
Right arrow Articles by DeMuth, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willey, J. C.
Right arrow Articles by DeMuth, J. P.
Am. J. Respir. Cell Mol. Biol., Volume 19, Number 1, July 1998 6-17

RAPID COMMUNICATION
Expression Measurement of Many Genes Simultaneously by Quantitative RT-PCR Using Standardized Mixtures of Competitive Templates

James C. Willey, Erin L. Crawford,* Clara M. Jackson, David A. Weaver, Jeremy C. Hoban, Sadik A. Khuder, and Jeffrey P. DeMuth*

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Medical College of Ohio, Toledo, Ohio


    Abstract
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Progress toward complete sequencing of all human genes through the Human Genome Project has already resulted in a need for methods that allow quantitative expression measurement of multiple genes simultaneously. It is increasingly recognized that relative measurement of multiple genes will provide more mechanistic information regarding cell pathophysiology than measurement of individual genes one by one or by methods that do not allow direct intergene comparison. In this study, previously described quantitative reverse transcription-polymerase chain reaction methods were modified in an effort to provide a rapid, simple method for this purpose. Internal standard competitive templates (CTs) were prepared for each gene and were combined in a single solution containing CTs for more than 40 genes at defined concentrations relative to one another. Any subsequent dilution of the CT mixture did not alter the relationship of one CT to another. Because the same CT standard solution or a dilution of it was used in all experiments, data obtained from different experiments were easily compared. The use of multiple CT mixtures with different housekeeping gene to target gene ratios provided a linear dynamic range spanning the range of expression of all genes thus far evaluated. CT stock solutions were used to simultaneously quantify the expression of 25 genes relative to beta -actin and glyceraldehyde-3-phosphate dehydrogenase in normal and malignant bronchial epithelial cells. Because the CT concentrations were known, data in the form of both absolute messenger RNA (mRNA) copy number and mRNA relative to housekeeping gene mRNA were obtained. The methods and reagents described will allow rapid, quantitative measurement of multiple genes simultaneously, using inexpensive and widely available equipment. Furthermore, the CT standard solution may be distributed to other investigators for interlaboratory standardization of experimental conditions.


    Introduction
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Several different methods for measurement of multiple genes simultaneously have been introduced over the last two years, including SAGE (1) and two forms of high-density oligonucleotide arrays (2, 3). These methods are still in development, are not widely available, rely on expensive equipment, are relatively insensitive, and at the present time are labor-intensive. The high-density array technology has potential for large-scale measurement of all human genes simultaneously, but in its current form requires at least 1 µg of RNA for each experiment (2). We have developed a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method that is not labor-intensive, does not require expensive equipment, and allows the rapid quantitative measurement of many genes simultaneously, using nanogram amounts of complementary DNA (cDNA) (4, 5). In an effort to scale up this method for the simultaneous measurement of large numbers of genes, we have thus far prepared internal standard competitive templates (CTs) for more than 100 genes. Here we describe the preparation of reagents, evaluation of experimental reproducibility and linear dynamic range, and application of the methods for simultaneous measurement of 25 genes relative to beta -actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in cultured human bronchial epithelial cells (BEC).

    Materials and Methods
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Reagents

PCR buffer (10×) was obtained from Idaho Technology, Inc. (Idaho Falls, ID). Taq polymerase (5 U/µl), M-MLV reverse transcriptase, M-MLV RT 5× buffer (250 mM Tris-HCl, pH 8.3; 375 mM KCl; 15 mM MgCl2; 50 mM dithiothreitol), oligo dT primers, RNasin, pGEM size marker, and deoxynucleotide triphosphates (dNTPs) were obtained from Promega (Madison, WI). Seakem LE and Nusieve agarose were obtained from FMC Bioproducts (Rockland, ME). TRI-REAGENT was obtained from Molecular Research Center, Inc. (Cincinnati, OH). Ribonuclease (RNase)-free water was obtained from GIBCO-BRL (Grand Island, NY). RPMI-1640 medium was obtained from Sigma (St. Louis, MO) and bronchial epithelial cell growth medium (BEGM)---which is bronchial epithelial cell basal medium containing bovine pituitary extract (52 µg/ ml), insulin (5 µg/ml), hydrocortisone (0.5 µg/ml), GA-1000 (0.1%), retinoic acid (0.1 ng/ml), transferrin (0.1 mg/ml), triiodothyronine (6.5 ng/ml), epinephrine (0.5 µg/ml), and human epidermal growth factor (0.5 ng/ml)---was obtained from Clonetics (San Diego, CA). LHC basal medium was obtained from Biofluids (Rockville, MD), and natural human fibronectin and type 1 rat-tail collagen were purchased from Collaborative Biomedical Products (Bedford, MA). All other chemicals and reagents were molecular biology grade.

Cells

Lung carcinoma cell lines NCI-H446, NCI-H82, NCI-N417, A549, A427, NCI-H2126, Calu-1, SW900, and NCI-H520 (American Type Culture Collection, Rockville, MD) were incubated in RPMI-1640 medium containing 10% fetal bovine serum (FBS) and 1 mM glutamine. Normal human bronchial epithelial cells (BEC) (Clonetics) lot numbers 10525 (49-yr-old Caucasian female), 17378 (10-yr-old Caucasian male), 17684 (20-yr-old Caucasian male), 6F0333 (41-yr-old Caucasian female), and 6F0450 (16-yr-old Hispanic female) were obtained from Clontics at passage two and were cultured as described (6) in the presence of serum-free BEGM. To incubate normal cells under the same conditions as tumor cells, BEGM was removed from cultured normal BEC and replaced with RPMI-1640 containing 10% FBS and 1 mM glutamine 16 to 18 h prior to RNA extraction. All cells were incubated at 37°C in the presence of 5% CO2 in 60-mm petri dishes that were coated with a solution of 10 ng/ml natural human fibronectin and 50 ng/ ml type 1 rat-tail collagen in LHC basal medium.

Sample Preparation and RNA Extraction

After cultured cells had reached 70 to 90% confluence, the medium was removed by aspiration and 1 ml TRI- REAGENT was added to each dish to lyse the cells, denature the proteins, and release the nucleic acids. Total RNA extraction and RT were performed as described by the TRI-REAGENT manufacturer and previously described methods (7). The cDNA samples were balanced with the CT mixture by dilution with TE buffer (10 mM Tris, 1 mM ethylenediamenetetraacetic acid) such that 1 µl, when included in a 10-µl PCR reaction containing 5 × 10-14 M beta -actin CT and beta -actin primers, yielded both native and CT beta -actin PCR products that were approximately equally intense on ethidium bromide-stained gels.

Quantitative PCR Amplification

Primers and CT standard mixtures. Oligo software was used to select primers based on the absence of stable duplex formation, low likelihood of false priming sites, and an optimal annealing temperature of 58°C (Table 1). When primers selected on this basis did not provide sufficient amplification (approximately 1 in 6 pairs), a new pair was selected. Rarely, it was necessary to prepare a third pair of primers. Amplification efficiency was considered sufficient when the amount of native template in 1 µl cDNA that had been diluted as described above (see SAMPLE PREPARATION AND RNA EXTRACTION section) and as little as 10-18 M target gene CT could be co-amplified and visualized on an ethidium bromide-stained agarose gel. Primers for all target genes and the two housekeeping genes that were evaluated in this study are listed in Table 1. Information regarding these as well as all other primers for CTs (a total of 40) that were included in the CT mixtures described here will be made available on the World Wide Web (http://darwin.mco.edu/medicine; click on Affiliated Groups and then on Pulmonary Research Lab).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Primers used for PCR amplification

CTs for each gene were included in every reaction to control for the unpredictable logarithmic amplification of PCR as well as for loading of gels (8). CTs were prepared according to the strategy previously described (9). CT primers were selected to ensure that CT PCR products were amplified by the same primers used to amplify native sequences and that they were sufficiently shorter than native PCR products to allow separation by agarose gel electrophoresis.

CTs were synthesized and amplified in reaction mixtures that contained 0.5 U Taq polymerase, 1 µl PCR buffer, 0.2 mM dNTPs, water, cDNA known to express the relevant gene (diluted as described previously), and 0.05 µg of the relevant primers in a total volume of 10 µl. For most genes, the forward primer for CT synthesis and amplification was the same as the one used to amplify the native sequence. However, the reverse primer was a hybrid formed by synthesizing the reverse primer (R) for native sequence amplification colinear with the indicated CT sequence (Table 1). In the case of GADD45, Max, and MUC1, the reverse primer was the same as the one used to amplify native sequence, but the forward primer was a hybrid formed by synthesizing the forward primer (F) for native sequence amplification colinear with the indicated CT sequence. The reaction mixtures were placed in capillary tubes and cycled 35 times in a Rapidcycler air thermocycler (Idaho Technology). Each cycle consisted of 5 s at 94°C, 10 s at 58°C, and 15 s at 72°C with a slope of 9.9, for a total amplification time of approximately 30 min. Three to 10 reactions for each CT were combined and electrophoresed through a 2% Nusieve agarose gel, and the expected PCR product was extracted from a gel slice using a QIAquick gel extraction column (Qiagen, Santa Clarita, CA).

The lengths of the CTs (see Table 1) were calculated by subtracting the position of the base pair (bp) that precedes the 5' end of the forward primer (for beta -actin, 191) from the position of the bp at the 5' end of the CT primer (for beta -actin, 587) and adding the length of the reverse primer (for beta -actin, 20). Thus, in the case of beta -actin, the value would be derived as follows: 587 - 191 + 20 = 416 bp.

The concentration of gel-purified CTs (in 30 µl of TE) was determined by electrophoresis of 1 µg pGEM size marker next to three lanes, each containing 1 to 5 µl of the purified CT PCR product through a 4% (3% Nusieve, 1% Seakem LE) agarose gel containing 0.5 µg/ml ethidium bromide. Bands were visualized with a Foto/Eclipse (Fotodyne, Hartland, WI) image analysis system, and densitometric analysis of digital images was performed using Collage software (Fotodyne) and a Power Mac 7100/66 (Apple Computer, Cupertino, CA). CT molarity was calculated after comparing the pixel quantity for the CT bands with that of a known amount of one of the pGEM fragments according to previously described methods (4).

CT mixtures derived from the same original stock were used for all of the data reported here. All CTs were combined in a mixture that contained 5 × 10-12 M beta -actin and 10-11 M of all other CTs, including GAPDH in TE buffer. This mixture was diluted 100-fold with 5 × 10-12 M beta -actin in TE buffer to make an A5 × 10e - 12/G-13/O-13 mixture where A is the CT molarity for beta -actin, G represents GAPDH, and O is all other genes. A5 × 10e - 12/G-13/O-13 was then diluted 10×, 100×, and 1,000× with A5 × 10e - 12 M/10-13 M beta -actin/GAPDH CT mixture in TE buffer to make A5 × 10e - 12/G-13/O-14, A5 × 10e - 12/G-13/O-15, and A5 × 10e - 12/G-13/O-16 mixtures, respectively. These solutions were then diluted 10× with TE buffer to give typical final working solutions that were A5 × 10e - 13/G-14/O-15, A5 × 10e - 13/G-14/O-16, and A5 × 10e - 13/G-14/O-17. A 1-µl volume of the desired mixture is included in each 10-µl PCR reaction; thus, the actual CT molarity in each reaction is 10-fold less than that in the working mixture. Because all dilutions were carried out after all CTs had been combined, the relationship of any target gene CT to any other target gene CT in all dilutions was the same as in the original mixture containing 5 × 10-12 M beta -actin and 10-11 M all other CTs. Thus, data obtained from experiments that involved the use of different dilutions of this original CT mixture were directly comparable. It is important to note that each of the primer pairs for a particular gene amplifies a single band from the CT mix when no native cDNA is present.

Although most PCR reactions reported here were conducted in an air thermocycler, many of the primer pairs were also used in an MJ PTC-100 block model (MJ Research, Inc., Watertown, MA) without significant difference in efficiency.

Preparation of PCR reaction mixtures. Reaction volumes were 10 µl and each contained 0.05 µg of each primer, 0.5 U Taq polymerase, 1 µl PCR buffer, 0.2 mM dNTPs, water, 1 µl of a CT mixture containing the desired molarity of each CT, and 1 µl cDNA diluted such that native beta -actin competed equally with the beta -actin CT present in the chosen CT mixture. To amplify each gene and its CT in individual reactions, each primer pair was placed in separate tubes and then mixed with an aliquot of the master mixture containing all other components of the reaction. The entire volume of mixed reaction mixture was transferred to a capillary tube and the open ends of the tube were heat-sealed. The reaction mixtures were cycled in a Rapidcycler air thermocycler as described above and electrophoresed on a 3% Nusieve/1% SeaKem agarose gel, and quantitative analysis was performed as described below. Levels of expression were reported as units of messenger RNA (mRNA)/106 beta -actin mRNA molecules.

Selection of the CT mixture with the most appropriate beta -actin/target gene ratio for an experiment was based on the relative cDNA concentration in the sample being analyzed and on the relative expression of the target gene compared with the housekeeping genes. The housekeeping genes used for all data reported in this study were beta -actin and GAPDH.

Samples of cDNA were diluted such that 1 µl competed equally with 105 to 106 molecules of beta -actin CT or 103 to 104 molecules of GAPDH CT. To prepare a reaction mixture containing 3 × 105 molecules of beta -actin CT, 1 µl of CT mixture containing beta -actin CT at a concentration of 5 × 10-13 M was included in a 10-µl reaction, giving a final concentration of 5 × 10-14 M. When cDNA samples were in balance with 5 × 10-14 M beta -actin CT, the concentration of target gene CT that was approximately in balance with the corresponding native template varied from one gene to another (Figure 1) and from one cell type to another. For the normal BEC population analyzed in Figure 1, the appropriate CT concentration in the reaction for CDK4 was 10-15 M (which in a 10-µl reaction volume amounted to 6,000 molecules), for p21 and spr1 it was 10-16 M (600 molecules in 10 µl), for GADD45 it was 10-18 M (6 molecules in 10 µl), and for all other genes it was 10-17 M (60 molecules in 10 ml).


View larger version (90K):
[in this window]
[in a new window]
 
Figure 1.   Results from a typical quantitative RT-PCR experiment. Mixtures of CTs were included in PCR reactions that also contained the desired primers (Table 1) and sufficient cDNA (from normal BEC lot 17378 cultured in BEGM) to compete equally with 5 × 10-14 M beta -actin CT. CT mixtures with different housekeeping gene-to-target gene ratios were used to optimize the native/CT ratio of PCR products for each gene. For each gene, the optimum native-to-CT ratio is as close to 1 as could be obtained. The CT molarity represents the molarity of the indicated CT (A represents beta -actin, G represents GAPDH, and O represents all other CTs) present in each 10-µl PCR reaction. PCR products were electrophoresed on a 4% (3% Nuseive, 1% Seakem LE) agarose gel, a digital image of the gel was obtained (Figure 3), and levels of expression in units of mRNA/106 beta -actin mRNA were calculated as described in MATERIALS AND METHODS. Note that the primers for the Max gene were designed to amplify four of its transcripts, each with a different PCR product length. We were able to quantify Max p22 and Max p21 transcripts, but the other expected PCR products were not observed in any of the cell types evaluated here. The cyclin E native PCR product represents three transcripts amplified in one band. TGaseII primers may also amplify a homolog of TGaseII. Primers for the Bcl-x gene were designed to amplify both L and S transcripts producing PCR products of differing lengths, both of which were quantifiable. Bcl-2 (not shown on this gel) primers have been designed to amplify both the alpha and beta transcripts to produce one band. MUC1 (not shown on this gel) also has two transcripts, both of which should be amplified by our primers. The observed PCR product represents the transmembraneous form; the secreted form (not observed in any samples analyzed here) would have appeared as a larger product because of the presence of two additional alternative sequence strings, one of which introduces an in-frame stop codon into the MUC1 open reading frame. Also note that unexpected PCR products were observed for the p53 and Bax-alpha genes; however, their presence does not interfere with analysis of the expected PCR products.


View larger version (38K):
[in this window]
[in a new window]
 
Figure 3.   Calculation of gene expression. Quantitative PCR reactions were performed as described in MATERIALS AND METHODS and in the legend to Figure 1. A digital image of the ethidium bromide-stained agarose gel shown in Figure 1 was evaluated for pixel intensity of beta -actin and CDK4 native (N), heterodimer (HD), and competitive template (CT) bands. For each gene, native and HD pixel values were corrected for size as described in MATERIALS AND METHODS. Half of the corrected HD pixel value was added to the corrected native value as well as to the CT value for each gene. The ratios of the resulting native values to the CT values for each gene were multiplied by the number of molecules of the relevant CT initially present in the PCR reaction before amplification. The resulting values were the numbers of molecules of native sequence contributed by cDNA for each gene initially present in the PCR reactions before amplification. The number of CDK4 mRNA molecules per 106 beta -actin mRNA molecules could then be derived.

Digital quantitation of PCR products and calculation of gene expression. The initial step in quantitation was digital image analysis. We analyzed pGEM size marker on every gel to identify the range for which the relationship between DNA fragment size (in bp) and ethidium bromide staining intensity (in pixels) was linear. An example of such an analysis is provided in Figure 2. On the basis of this control, we could ensure that the bands being analyzed were all within the dynamic range of the image analysis system. When a band was not within the linear range, we could increase or decrease the amount of cDNA or CT in the reaction mixture and/or change the relationship between housekeeping gene and target gene CTs. The bands were then quantified on the basis of total ethidium bromide staining.


View larger version (23K):
[in this window]
[in a new window]
 
Figure 2.   Pixels relative to micrograms of pGEM size marker. One microgram of digested pGEM plasmid was electrophoresed on a 4% agarose gel and the number of micrograms in each band was calculated by dividing the number of bp in the digestion fragment by the number of bp in the undigested pGEM plasmid. Bands 1-8 were plotted. The largest (top) three bands were not plotted because they were not within the linear range.

Ethidium bromide staining was proportional to the total number of bp present. The total number of bp present was related to both the size and number of molecules present in each band. Quantification of mRNA expression of target genes was determined in the following manner, using CDK4 expression as an example (Figure 3). Because we were interested in the number of molecules present in each band, independent of size, the staining intensity of native cDNA PCR product was arbitrarily corrected to the size of the CT PCR product. Following correction, the relative intensity of the native and CT bands was directly related to the number of molecules in each band. For the example shown in Figure 3, the native beta -actin homodimer pixel quantity was corrected for size as follows: 712,800 pixels × 416 bp (CT size)/532 bp (native size) = 557,377 pixels.

A third band that migrated between the native and CT PCR products (Figures 1 and 3) was often observed. This band represented a heterodimer (HD) that formed between one strand of native and one strand of CT, and its intensity was related to the amount of PCR product loaded. The HD, if present, was taken into account when determining mRNA expression. For the example shown in Figure 3, the beta -actin HD pixel intensity was corrected for size as described previously (to 119,749 pixels). Next, half of the HD pixel value was added to the corrected native pixel value (557,377 pixels + 59,875 pixels = 617,252 pixels) and half was added to the CT pixel intensity (690,592 pixels + 59,875 pixels = 750,467 pixels). The initial number of native beta -actin molecules present in the PCR reaction then was determined by multiplying the ratio of the corrected native to CT beta -actin pixel intensities by the initial number of beta -actin CT molecules present in the PCR reaction (3 × 105 molecules): 617,252 pixels/750,467 pixels × 3 × 105 molecules = 246,747 molecules.

The initial number of native CDK4 molecules present in the PCR reaction was determined in the same manner. The native pixel intensity was first corrected for size: 418,080 pixels × 310 bp/396 bp = 327,285 pixels. The HD was then corrected for size as described previously (to 29,334 pixels), and half of this value was added to the corrected native pixel value and to the CT pixel value. The ratio of these corrected native and CT band intensities was multiplied by the initial number of CDK4 CT molecules present in the reaction (6 × 103 molecules): 341,952 pixels/ 147,723 pixels × 6 × 103 molecules = 13,889 molecules. Thus we determined that there were 13,889 molecules of CDK4 mRNA per 246,747 molecules of beta -actin mRNA in this sample, which may be converted to 56,288 molecules of CDK4 mRNA per 106 molecules of beta -actin mRNA (Figure 1).

Experiments were performed in duplicate or triplicate unless otherwise stated (see footnotes for Tables 2 and 3). Because all experiments were performed with dilutions of the same CT mixture (i.e., the ratio of any target gene CT to any other target gene CT was constant in all experiments), and because amplification efficiencies of all native sequences relative to all corresponding CT sequences were approximately equal for all genes thus far evaluated (Figure 4 and data not shown), we were able to detect intersample differences in the expression of many individual genes as well as alterations in the expression of each gene relative to all other genes.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Cell cycle gene expression in cultured normal versus malignant BEC

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3
Apoptosis, DNA repair, and differentiation gene expression in cultured normal versus malignant BEC


View larger version (23K):
[in this window]
[in a new window]
 
Figure 4.   Amplification efficiency of native relative to CT for beta -actin, GAPDH, c-myc, E2F-1, and p21. For each gene an assumption of the initial number of native molecules in a particular cDNA sample was made on the basis of previous experiments. Native cDNA was placed in a PCR master mix containing all components of the PCR reaction except for the CT molecules. Aliquots of the master mix were then transferred to individual reaction tubes containing varying amounts of CT molecules (from 5 × 10-12 to 5 × 10-14 M for beta -actin and from 10-15 to 10-17 M for the other genes). The ratio of the assumed initial number of native molecules to the known initial number of CT molecules prior to amplification was plotted along the x-axis. The ratio of the pixel intensity for the ethidium bromide-stained native PCR product to that of the CT PCR product was plotted along the y-axis. The slopes and correlation coefficients were beta -actin (1.24, r2 = 0.99), GAPDH (0.74, r2 = 0.99), c-myc (0.79, r2 = 0.93), E2F-1 (1.17, r2 = 0.99), and p21 (1.23, r2 = 0.95). Because each graph was linear and the slopes were approximately 1, the amplification efficiencies of each native product from cDNA and corresponding CT were approximately equal.

Data Analysis

All statistical analyses were carried out using SAS software (version 6.11, 1996; SAS Institute, Cary, NC). The natural log of all expression values was used to normalize all data for statistical comparison. This was necessary because of the wide fluctuations in gene expression among individuals within populations (e.g., c-myc in small-cell carcinoma, E2F-1 in normal, and p21 in small-cell and squamous cell populations).

Cell Size Determination

Cultured cells were assessed digitally using an Olympus IMT2 inverted microscope and Collage 4.0 or NIH image 1.59 software. The average number of pixels per cell was determined from at least 25 cells in each population.

    Results
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Results from a Typical Experiment

A typical quantitative experiment that provided data for 26 genes including beta -actin and GAPDH in cultured normal BEC lot 17378 incubated in BEGM is shown in Figure 1. For this experiment all genes were quantifiable except for cyclin D1 and NSE. The cyclin D1 primers that were chosen were inefficient, and thus neither the native nor the CT amplified sufficiently for quantification. Subsequently, additional cyclin D1 primers with greater efficiency were identified. A new cyclin D1 CT that was amplified by the second set of primers was prepared and has been included in subsequent CT mixtures. NSE was not quantifiable in this experiment because the CT concentration of 10-18 M was too low to compete with the amount of native template present. NSE was quantified in this sample by including CT molarities of A5 × 10e - 14/G-15/O-17 in subsequent PCR reactions.

Amplification Efficiency of Native Relative to Varying Amounts of CT

The reliability of this method depends in part on a linear relationship between the amplification of native sequences relative to CT sequences. We have examined this relationship for 16 genes including beta -actin, GAPDH, c-myc, E2F-1, and p21 (Figure 4 and data not shown). Because all correlation coefficients were close to 1, we were confident in determining gene expression when the imbalance between native and CT band densities was up to 10-fold. When the imbalance between native and CT band densities was greater than 10-fold, we selected a CT mixture with a more appropriate beta -actin/target gene ratio for repeat analysis.

Effects of Unexpected PCR Products on Quantitation

For some genes (e.g., p53 and Bax-alpha ) a larger, unexpected PCR product representing either an alternatively spliced transcript or a cDNA sequence derived from another gene that contains sequence homology to the relevant primers was observed (Figure 1). No bands were visible between the native and unexpected bands. This indicates that no HD between the native or CT sequences and the unexpected product was formed, probably because there was not sufficient sequence homology. It is possible that co-amplification of the alternate sequence will reduce the amount of native and CT sequence amplified because of competition for primers, but there is no reason why it would alter the relative amplification efficiency of native and CT. It was possible to compare the unexpected amplification product with CT amplification to determine whether there was any intersample difference in expression. No significant associaton with malignancy was observed.

Reproducibility

Between five and 14 replicate measurements of GAPDH relative to beta -actin expression were performed with cDNA samples from the 19 cell populations represented in Tables 2 and 3. The standard deviation (SD) was =< 25% of the mean in nine samples and =< 50% of the mean in all but one sample (in which the SD was 52% of the mean). Thus, in most experiments, it will be possible to identify 2-fold changes in gene expression with confidence.

Accuracy

Knowledge of the value of the slope in these experiments is a prerequisite to accurate determination of gene expression and accurate determination of the relative expression of one gene to another. Because the slope has not been higher than 2 or lower than 0.5 in a total of 16 genes evaluated thus far (Figure 4 and data not presented), the effect of differences in the slope is small relative to intersample variation in expression.

GAPDH/beta -actin Ratio Relationship to Cell Size

There is variation in the GAPDH/beta -actin ratio from one cell sample to another (Table 2). Because the ratio tended to be higher in the malignant cell lines, we hypothesized that intercell population variation in the ratio was related to cell size. A significant relationship (P < 0.001) between two-dimensional cell surface area in culture and GAPDH/ beta -actin ratio was observed (Figure 5).


View larger version (20K):
[in this window]
[in a new window]
 
Figure 5.   Scatter plot of two-dimensional cell size versus GAPDH/beta -actin ratio (y = -5.224x + 18.503, r2 = 0.367). All five normal cultured BEC incubated in RPMI containing 10% FBS and in BEGM, eight tumor cell lines that are listed in Tables 2 and 3, and one additional carcinoma cell line (NCI-H460) were assessed digitally for two-dimensional cell surface area. Digital images of cells were prepared using an Olympus IMT2 inverted microscope and Collage 4.0 or NIH image 1.59 software. The average number of pixels per cell was determined from at least 25 cells in each population. The average value of at least five determinations of GAPDH relative to beta -actin mRNA in each cell population was determined as described in the footnotes to Table 2.

Quantitation of Gene Expression by Multiplex or Nonmultiplex RT-PCR

The CT mixture described here can be used to quantitatively measure gene expression either by multiplex competitive RT-PCR (4, 5) or by nonmultiplex competitive RT-PCR. In multiplex RT-PCR, the native and CTs for both the housekeeping gene and the target gene are amplified in the same reaction. For nonmultiplex RT-PCR, the experiment is designed the same as for multiplex RT-PCR except that primers for only one gene are included in each PCR reaction tube. Because of the constant relationship between CT concentrations in each experiment and the use of master mixtures, the results obtained by either method are highly reproducible. A protocol for quantitative nonmultiplex RT-PCR was developed because multiplex RT-PCR does not always work in air thermocyclers, yet the use of air thermocyclers significantly reduces the amount of time necessary for each experiment. Assessment of a single sample by multiplex or nonmultiplex RT-PCR in an MJ PTC-100 thermal induction thermocycler (MJ Research, Inc.) was compared with nonmultiplex RT-PCR in a Rapidcycler air thermocycler (Idaho Technologies; Figure 6). The number of CYP2A6 mRNA molecules per 106 GAPDH mRNA molecules was determined for each PCR method (see legend to Figure 6), a mean was determined for the results, and the standard deviation was less than 50% of the mean. Therefore, nonmultiplex competitive RT-PCR in an air thermocycler was used to obtain all of the data reported here because it was far less time-consuming and labor-intensive. When the available amount of cDNA is limited, multiplex competitive RT-PCR is preferable because both the housekeeping gene and the target gene can be quantified from the same cDNA aliquot.


View larger version (29K):
[in this window]
[in a new window]
 
Figure 6.   Multiplex RT-PCR versus nonmultiplex RT-PCR. Quantitative reactions for the housekeeping control gene GAPDH (lanes 2, 3, and 5) as well as for the cytochrome p450 gene CYP2A6 (lanes 2, 4, and 6) were performed by multiplex PCR in an MJ-100 thermocycler (lane 2), by nonmultiplex PCR in an MJ-100 (lanes 3 and 4), or by nonmultiplex PCR in an air thermocycler (lanes 5 and 6). The number of CYP2A6 mRNA molecules per 106 GAPDH mRNA molecules for each PCR method was determined to be 4,340 molecules, 5,750 molecules, and 7,960 molecules of CYP2A6 mRNA for lanes 2, 4, and 6, respectively. pGEM size marker was loaded in lane 1.

Genomic DNA Contamination

Detecting genomic DNA contamination in RT-PCR reactions was discussed previously (4). Whenever possible, we designed primers for RT-PCR that flank or cross introns in the genomic sequence. Thus, if genomic DNA did contaminate the RNA preparation, and this genomic DNA was carried over through the RT into the cDNA, the PCR product (if amplified) derived from genomic DNA would be larger than the PCR product derived from cDNA. Bands that might represent genomic DNA contamination were not observed in any of the experiments reported here. Circumstances that would increase the chances of significant interference in cDNA quantitation from contaminating genomic DNA include (1) an RNA preparation with a high level of genomic DNA contamination, and (2) a low expression of the gene being assessed.

Thus, although others have advocated including a DNase step following RNA extraction, it is not necessary (and is potentially highly deleterious by increasing the chance of losing sample and contaminating other reagents with DNase) when using the methods described here. However, it is advisable to assess each new cDNA preparation for genomic DNA contamination by including undiluted cDNA in a PCR reaction along with primers for a gene known to be expressed at low levels and that flank an intron. In these experiments, primers for PCNA, MUC1, and GADD45 flanked an intron and each was expressed at low levels in many of the samples evaluated in this study. Amplification of genomic DNA with these primers would produce larger PCR products than amplification of cDNA. No bands were observed that would correspond to genomic DNA following amplification and electrophoresis using any cDNA sample evaluated in this study.

    Discussion
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Here is described a quantitative competitive RT-PCR method using standardized mixtures of CTs to measure rapidly and accurately the mRNA expression of many genes simultaneously. This method allows the detection of not only variation in gene expression levels from one sample to another, but also the intergene mRNA stoichiometric relationships in the same sample. It is hypothesized that intergene expression alterations will be more mechanistically related to basic phenotypic differences than variation in expression of individual genes. This hypothesis was tested by assessing the relative expression of 25 genes involved in cell cycle control, apoptosis, DNA repair, and differentiation compared with the expression of two housekeeping genes in nine cultured human lung tumor cell lines versus five cultured normal BEC samples. One important observation was that the gene expression index c-myc × E2F-1/p21 better discriminated between normal and malignant BEC than the expression of any single cell cycle gene (10). Thus, data obtained in those experiments support our hypothesis. Another important observation was that the spr1 gene was significantly expressed and inducible in all cultured normal BEC evaluated, whereas it was neither expressed nor inducible in all carcinoma cell lines evaluated (11).

We are preparing reagents for additional genes and plan to combine them in batches of approximately 50. Theoretically, it would be possible to prepare a mixture containing CTs for all human genes (50-100,000), but for most experiments in which fewer genes will be evaluated the CTs for the genes not being studied would be wasted. CT mixtures for all human genes may be desirable when using the method in combination with high-density oligonucleotide arrays.

It is not yet known how many genes must be measured to define optimally any particular phenotype. This likely will depend on the cell type and specific goals of the investigator. For most purposes, it is possible that measurement of no more than 500 genes will be necessary to define a phenotype optimally. If this is the case, using the methods described here, 500 µl of CT mixture and 500 ng of cDNA would be needed for a single experiment. However, through miniaturization and use of capillary electrophoresis it may be possible to reduce the amount needed to 50 µl and 50 ng, respectively.

The method used in these studies allows rapid, quantitative measurement of many genes simultaneously and it allows direct comparison of gene expression with that of an internal standard. The same standards can be made available to interested laboratories, allowing development of databases with a common reference standard.

The CT mixtures described here and similar CT mixtures have been used to evaluate expression of the genes described in this paper as well as cytokine, antioxidant enzyme, and xenobiotic metabolism genes in primary normal and malignant lung cells, including bronchial brush, alveolar macrophage, lung parenchyma, and primary bronchogenic carcinoma specimens (4 and J. C. Willey, unpublished data).

The reproducibility described here will allow detection of differences in expression from one sample to another of 2-fold or greater. This is equivalent to or better than that observed with most other measures of gene expression, including Northern blotting and RNase protection assays. Based on data from Figure 1, the GAPDH value was reproducible within 30% even when three different CT mixtures were used. Although 30% may seem like a large variation for most assays, it is better than could be expected with Northern analysis. The method described here is also more sensitive than other gene expression methods. For example, in typical experiments 106 cells yield enough RNA (approximately 2 to 5 µg) to provide cDNA for 5 × 102 to 5 × 103 assays. Thus, with the method described here, multiple gene expression studies can be conducted when a limited amount of tissue is available. In contrast, the same amount of RNA typically would not be sufficient for one Northern blot assay or for more than one or two RNase protection assays. Furthermore, with this method, as opposed to Northern blot or RNase protection assays, it is possible to obtain more replicates because each experiment requires 4 h as opposed to as many as 4 d, and the method is far less prone to lab error. With larger numbers of replicates it is expected that the standard deviation would decrease and the ability to identify small differences in gene expression would increase.

    Footnotes

Address correspondence to: Dr. James C. Willey, Div. of Pulmonary and Critical Care Medicine, Dept. of Medicine, Medical College of Ohio, 3000 Arlington Ave., Toledo, OH 43699-0008. E-mail: jwilley{at}opus.mco.edu

(Received in original form June 21, 1997 and in revised form January 12, 1998).

* These authors have contributed equally to this manuscript.

Acknowledgments: These studies were funded by the following grants: NIEHS R01 05719 and NIEHS P01 01640.

Abbreviations BEC, bronchial epithelial cells; BEGM, bronchial epithelial cell growth medium; bp, base pair(s); CT, competitive template; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HD, heterodimer; RNase, ribonuclease; RT-PCR, reverse transcription-polymerase chain reaction; TE buffer, 10 mM Tris, 1 mM ethylenediamenetetraacetic acid.

    References
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1. Velculescu, V. E., L. Zhang, B. Vogelstein, and D. W. Kinzler. 1995. Serial analysis of gene expression. Science 270: 484-487 [Abstract/Free Full Text].

2. Lockhart, D. J., H. Dong, M. C. Byrne, M. T. Follettie, M. V. Gallo, M. S. Chee, M. Mittmann, C. Wang, M. Kobayashi, H. Horton, and E. L. Brown. 1996. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14: 1675-1680 . [Medline]

3. Schena, M., D. Shalon, R. W. Davis, and P. O. Brown. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470 [Abstract/Free Full Text].

4. Willey, J. C., E. L. Coy, M. W. Frampton, A. Torres, M. J. Apostolakos, G. Hoehn, W. H. Schuermann, W. G. Thilly, D. E. Olson, J. R. Hammersley, C. L. Crespi, and M. J. Utell. 1997. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol. 17: 114-124 [Abstract/Free Full Text].

5. Apostolakos, M. J., W. H. T. Schuermann, M. W. Frampton, M. J. Utell, and J. C. Willey. 1994. Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal. Biochem. 213: 277-284 .

6. Lechner, J. F., and M. A. LaVeck. 1985. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J. Tissue Culture Methods 9: 43-48 .

7. Willey, J. C., E. Coy, C. Brolly, M. J. Utell, M. W. Frampton, J. Hammersley, W. G. Thilly, D. Olson, and K. Cairns. 1996. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am. J. Respir. Cell Mol. Biol. 14: 262-271 [Abstract].

8. Gilliand, G., S. Perrin, K. Blanchard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87: 2725-2729 [Abstract/Free Full Text].

9. Celi, F. S., M. E. Zenilman, and A. R. Shuldiner. 1993. A rapid and versatile method to synthesize internal standards for competitive PCR. Nucleic Acids Res. 21: 1047 [Free Full Text].

10. DeMuth, J. P., D. A. Weaver, E. L. Crawford, C. M. Jackson, J. C. Hoban, S. A. Khuder, and J. C. Willey. 1998. The gene expression index c-myc × E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 19: 18-24 [Abstract/Free Full Text].

11. DeMuth, J. P., D. A. Weaver, E. L. Crawford, C. M. Jackson, and J. C. Willey. 1998. Loss of spr1 expression measurable by quantitative RT-PCR in human bronchogenic carcinoma cell lines. Am. J. Respir. Cell Mol. Biol. 19: 25-29 [Abstract/Free Full Text].





This article has been cited by other articles:


Home page
Ann OncolHome page
C. H. Smorenburg, G. J. Peters, C. J. van Groeningen, P. Noordhuis, K. Smid, A. M. G. H. van Riel, W. Dercksen, H. M. Pinedo, and G. Giaccone
Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase
Ann. Onc., January 1, 2006; 17(1): 35 - 42.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Pintus, B. Tadolini, A. M Posadino, B. Sanna, M. Debidda, C. Carru, L. Deiana, and C. Ventura
PKC/Raf/MEK/ERK signaling pathway modulates native-LDL-induced E2F-1 gene expression and endothelial cell proliferation
Cardiovasc Res, October 1, 2003; 59(4): 934 - 944.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
K. A. Warner, E. L. Crawford, A. Zaher, R. J. Coombs, H. Elsamaloty, S. L. Roshong-Denk, I. Sharief, G. V. Amurao, Y. Yoon, A. Y. Al-Astal, et al.
The c-myc x E2F-1/p21 Interactive Gene Expression Index Augments Cytomorphologic Diagnosis of Lung Cancer in Fine-Needle Aspirate Specimens
J. Mol. Diagn., August 1, 2003; 5(3): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Suzuki, K. Koyama, A. Darnel, H. Ishibashi, S. Kobayashi, H. Kubo, T. Suzuki, H. Sasano, and Z. S. Krozowski
Dexamethasone Upregulates 11{beta}-Hydroxysteroid Dehydrogenase Type 2 in BEAS-2B Cells
Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1244 - 1249.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. A. Herness and R. K. Naz
A Novel Human Prostate-specific Gene-1 (HPG-1): Molecular Cloning, Sequencing, and Its Potential Involvement in Prostate Carcinogenesis
Cancer Res., January 15, 2003; 63(2): 329 - 336.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. Kennedy, E. Omran, S. M. Periyasamy, J. Nadoor, A. Priyadarshi, J. C. Willey, D. Malhotra, Z. Xie, and J. I. Shapiro
Effect of Chronic Renal Failure on Cardiac Contractile Function, Calcium Cycling, and Gene Expression of Proteins Important for Calcium Homeostasis in the Rat
J. Am. Soc. Nephrol., January 1, 2003; 14(1): 90 - 97.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. R. Kroep, W. J. P. Loves, C. L. van der Wilt, E. Alvarez, I. Talianidis, E. Boven, B. J. M. Braakhuis, C. J. van Groeningen, H. M. Pinedo, and G. J. Peters
Pretreatment Deoxycytidine Kinase Levels Predict in Vivo Gemcitabine Sensitivity
Mol. Cancer Ther., April 1, 2002; 1(6): 371 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Suzuki, A. D. Darnel, J.-I. Akahira, N. Ariga, S. Ogawa, C. Kaneko, J. Takeyama, T. Moriya, and H. Sasano
5{{alpha}}-Reductases in Human Breast Carcinoma: Possible Modulator of in Situ Androgenic Actions
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2250 - 2257.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C.-M. Li, J. Khosla, I. Pagan, P. Hoyle, and P. L. Sannes
TGF-beta 1 and fibroblast growth factor-1 modify fibroblast growth factor-2 production in type II cells
Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1038 - L1046.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
B W S Robinson, D J Erle, D A Jones, S Shapiro, W J Metzger, S M Albelda, W C Parks, and A Boylan
Recent advances in molecular biological techniques and their relevance to pulmonary research
Thorax, April 1, 2000; 55(4): 329 - 339.
[Full Text]


Home page
Cancer Res.Home page
E. L. Crawford, S. A. Khuder, S. J. Durham, M. Frampton, M. Utell, W. G. Thilly, D. A. Weaver, W. J. Ferencak, C. A. Jennings, J. R. Hammersley, et al.
Normal Bronchial Epithelial Cell Expression of Glutathione Transferase P1, Glutathione Transferase M3, and Glutathione Peroxidase Is Low in Subjects with Bronchogenic Carcinoma
Cancer Res., March 1, 2000; 60(6): 1609 - 1618.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. T. Allen, R. A. Knight, C. A. Bloor, and M. A. Spiteri
Enhanced Insulin-Like Growth Factor Binding Protein-Related Protein 2 (Connective Tissue Growth Factor) Expression in Patients with Idiopathic Pulmonary Fibrosis and Pulmonary Sarcoidosis
Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 693 - 700.
[Abstract] [Full Text]


Home page
BloodHome page
M. G. Rots, R. Pieters, G. J. Peters, C. H. van Zantwijk, R. Mauritz, P. Noordhuis, J. C. Willey, K. Hahlen, U. Creutzig, G. Janka-Schaub, et al.
Circumvention of Methotrexate Resistance in Childhood Leukemia Subtypes by Rationally Designed Antifolates
Blood, November 1, 1999; 94(9): 3121 - 3128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
W. N. Rom
Assessment of Activation, Differentiation, and Carcinogenesis of Lung Cells by Quantitative Competitive RT-PCR
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 3 - 5.
[Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. P. DeMuth, C. M. Jackson, D. A. Weaver, E. L. Crawford, D. S. Durzinsky, S. J. Durham, A. Zaher, E. R. Phillips, S. A. Khuder, and J. C. Willey
The Gene Expression Index c-myc נE2F-1/p21 Is Highly Predictive of Malignant Phenotype in Human Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 18 - 24.
[Abstract] [Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. P. DeMuth, D. A. Weaver, E. L. Crawford, C. M. Jackson, and J. C. Willey
Loss of spr1 Expression Measurable by Quantitative RT-PCR in Human Bronchogenic Carcinoma Cell Lines
Am. J. Respir. Cell Mol. Biol., July 1, 1998; 19(1): 25 - 29.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager